Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

SP, chloroquine, amodiaquine, primaquine, artesunate

SR-A + Epratuzumab

Standard of Care PO (oral) antibiotics

Standard treatment: Control arm

Sufentanil 30 MCG Sublingual Tablet

Surgery with an external ring fixator

TKI

TPOXX

Tadalafil

Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

Tenofovir gel

Teriparatide

Thalidomide

The Placebo Nebuliser Solution is a solution dosage form for nebulisation identical to Treprostinil Nebuliser Solution drug product except for the absence of the treprostinil drug substance., Treprostinil

Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine

Tobramycin Injection

Tranexamic Acid

Treatment group

Treprostinil, The Placebo Nebuliser Solution is a solution dosage form for nebulisation identical to Treprostinil Nebuliser Solution drug product except for the absence of the treprostinil drug substance.

Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)

UB-421

UI022 or UI023 and co-administration of matching placebo

UI05MSP015CT

UT-15

Frequently asked questions